Use of sustained-release moxidectin to prevent eyeworm (Thelazia callipaeda) infection in dogs.
Rossi
L
L
Dipartimento di Produzioni Animali, Epidemiologia ed Ecologia, Università di Torino, Via Leonardo da Vinci 44, 10095 Grugliasco, Italy.
Rigano
C
C
Tomio
E
E
Frassetto
D
D
Ferroglio
E
E
D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D004283:Dog Diseases / Q000188:drug therapy / Q000517:prevention & control*; D004285:Dogs; D005260:Female; D007279:Injections, Subcutaneous / Q000662:veterinary; D007303:Insect Vectors / Q000469:parasitology; D018942:Macrolides / Q000627:therapeutic use; D008297:Male; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D012621:Seasons; D017205:Spirurida Infections / Q000188:drug therapy / Q000517:prevention & control / Q000662:veterinary*; D013802:Thelazioidea / Q000187:drug effects* / Q000254:growth & development; D016896:Treatment Outcome
D000871:Anthelmintics; D003692:Delayed-Action Preparations; D018942:Macrolides; D009883:Ophthalmic Solutions; C027837:moxidectin